Article Contents ::
- 1 Details About Generic Salt :: Isradipi
- 2 Main Medicine Class:: Calcium channel blocker
- 3 (iss-RAHD-ih-peen) DynaCirc, DynaCirc CR Class: Calcium channel blocker
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Isradipi
Main Medicine Class:: Calcium channel blocker
(iss-RAHD-ih-peen)
DynaCirc, DynaCirc CR
Class: Calcium channel blocker
Drugs Class ::
Action Reduces systemic vascular resistance and BP by inhibiting movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle and myocardium.
Indications for Drugs ::
Indications Treatment of hypertension.
Drug Dose ::
Route/Dosage
ADULTS: PO 2.5 to 10 mg/day in 2 divided doses (max dose 20 mg/day).
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. CHF: Use with caution in patients with CHF.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Peripheral edema; flushing; palpitations; angina; tachycardia; hypotension; syncope; CHF; MI; atrial or ventricular fibrillation. CNS: Dizziness; lightheadedness; headache; fatigue; lethargy; weakness; shakiness; psychiatric disturbances. DERM: Rash. GI: Nausea; diarrhea; constipation; abdominal discomfort; cramps; dyspepsia; vomiting. GU: Urinary frequency; micturition disorders; sexual difficulties. RESP: Shortness of breath; dyspnea; wheezing. OTHER: Transient ischemic attack; stroke.
Drug Mode of Action ::
Action Reduces systemic vascular resistance and BP by inhibiting movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle and myocardium.
Drug Interactions ::
Interactions None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note cardiovascular disease.
- Monitor BP, cardiac and respiratory function during therapy.
- Monitor for dizziness, headache, and peripheral edema.
- Assist patient with ambulation if dizziness occurs.
|
Drug Storage/Management ::
Administration/Storage
- May administer with or without food.
- Store in tightly closed container at room temperature. Protect from light.
Drug Notes ::
Patient/Family Education
- Explain that dosage will be tapered slowly before stopping to avoid withdrawal symptoms. Warn patient that sudden discontinuation may cause serious chest pain.
- Tell patient to brush and floss teeth regularly to minimize gum changes (eg, overgrowth of gums).
- Instruct patient to report the following symptoms to physician: Irregular heart beat, shortness of breath, swelling of hands or feet, pronounced dizziness, constipation, nausea, or hypotension.
- Advise patient that drug may cause dizziness and to use caution while driving or performing other tasks requiring mental alertness.